Results 11 to 20 of about 503,005 (217)

Polio inactivated vaccine costs into routine childhood immunization in Brazil [PDF]

open access: yesRevista de Saúde Pública, 2015
OBJECTIVE To analyze the costs of vaccination regimens for introducing inactivated polio vaccine in routine immunization in Brazil. METHODS A cost analysis was conducted for vaccines in five vaccination regimens, including inactivated polio vaccine ...
Ana Marli Christovam Sartori   +4 more
doaj   +2 more sources

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence [PDF]

open access: yes, 2012
Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals ...
Assir N   +11 more
core   +1 more source

Evaluation of cellular and humeral immune response of sheep vaccinated with inactivated Rift Valley Fever vaccine adjuvanted with Montanide Gel

open access: yesJournal of Applied Veterinary Sciences, 2020
Rift Valley Fever (RVF) is an acute infectious zoonotic arthropod - born viral disease, affecting many species of animals with causing great economic losses in animal wealth.
Abd El Rahman S.E.   +3 more
doaj   +1 more source

Inactivated vaccine against Aujeszky's disease

open access: yesVeterinary World, 2021
Background and Aim: The Aujeszky's disease, also known as Pseudorabies, remains one of the most problematic fulminant diseases in domestic animals, affecting the central nervous system. The study aimed to investigate the effect of an inactivated vaccine against Aujeszky's disease based on "Kordai" virus strain.
Zhanat B. Kondibaeva   +9 more
openaire   +4 more sources

Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial [PDF]

open access: yes, 2010
Background: Current conventional vaccination approaches do not induce potent CD8 T-cell responses for fighting mostly variable viral diseases such as influenza, avian influenza viruses or HIV.
van der Werf, Sylvie   +39 more
core   +2 more sources

Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study

open access: yesFrontiers in Immunology, 2023
IntroductionChina experienced a record surge of coronavirus disease 2019 cases in December 2022, during the pandemic.MethodsWe conducted a randomized, parallel-controlled prospective cohort study to evaluate efficacy and antibody duration after a fourth ...
Nani Xu   +13 more
doaj   +1 more source

Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice

open access: yes, 2023
Mumps is an acute infectious disease caused by the mumps virus (MuV). Despite high global vaccination coverage, mumps outbreaks continue to occur, even in vaccinated populations.
Hyeran Won   +11 more
core   +1 more source

Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep

open access: yesVirology Journal, 2023
Background The live-attenuated Rift Valley Fever Smithburn (SB) vaccine is one of the oldest products widely used in ruminants for control of RVF infections.
Matome Selina Matsiela   +3 more
doaj   +1 more source

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

open access: yesEmerging Microbes and Infections, 2021
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries.
Jialu Zhang   +18 more
doaj   +1 more source

Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS. [PDF]

open access: yes, 2014
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV) and has been observed in the macaque model using inactivated simian immunodeficiency virus (SIV).
Mark Robinson   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy